|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C67.9 |
Malignant neoplasm of bladder, unspecified
|
C679 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.30%
|
22.56%
|
8.53%
|
4.52%
|
2.74%
|
1.87%
|
1.28%
|
0.91%
|
0.59%
|
0.45%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C67.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
46,426
|
46,752
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
38,164
|
38,184
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
38,139
|
38,333
|
|
80053
|
COMPREHEN METABOLIC PANEL |
36,013
|
36,018
|
|
51720
|
TREATMENT OF BLADDER LESION |
24,017
|
24,187
|
|
J3010
|
FENTANYL CITRATE INJECTION |
20,554
|
30,373
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
20,065
|
20,589
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
19,897
|
1,851,884
|
|
J2405
|
ONDANSETRON HCL INJECTION |
18,234
|
85,073
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
18,080
|
429,942
|
|
52000
|
CYSTOURETHROSCOPY |
17,719
|
17,720
|
|
J9030
|
BCG LIVE INTRAVESICAL 1MG |
15,785
|
621,956
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
13,483
|
13,532
|
|
87086
|
URINE CULTURE/COLONY COUNT |
13,457
|
13,507
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
13,203
|
103,207
|
|
80048
|
METABOLIC PANEL TOTAL CA |
12,984
|
13,001
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
12,850
|
50,497
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
12,364
|
30,735
|
|
81003
|
URINALYSIS AUTO W/O SCOPE |
12,066
|
12,113
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
11,984
|
13,524
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C67.9 related to the following DRG Codes:
656-658
686-688
|
